GeoVax Labs Inc (GOVX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.60
• Market Cap: $2.88M
• EPS: $-31.75
• 52-Week High: $47.12
• 52-Week Low: $1.26

Market Sentiment

GeoVax Labs Inc currently has a Neutral sentiment score of 0.06.

About GeoVax Labs Inc

GeoVax Labs, Inc. is a clinical-stage biotechnology company headquartered in Smyrna, Georgia, dedicated to the development of pioneering vaccines and immunotherapies for infectious diseases and cancers. Utilizing a proprietary modified vaccinia Ankara virus-like particle platform, the company is advancing its innovative pipeline of therapeutic candidates through multiple clinical trial stages. GeoVax's focus on addressing critical unmet medical needs and its commitment to cutting-edge vaccine...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for GeoVax Labs Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does GOVX pay dividends?

GeoVax Labs Inc (GOVX) does not currently pay a regular dividend.

What is GOVX's market cap?

GeoVax Labs Inc (GOVX) has a market capitalization of $2.88M with a current stock price of $1.60.